Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Amylin Pharmaceuticals | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Amylin Pharmaceuticals

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Daniel M. Bradbury has been named president and chief executive officer, Amylin Pharmaceuticals, Inc., effective March 1, 2007. He will succeed Ginger L. Graham, who has led the company since 2003.

In June 2006, Mr. Bradbury was named president and chief operating officer and became a member of the board of directors. He previously served as executive vice president from June 2000 until his promotion to chief operating officer in June 2003. He joined the company in 1994 and has held officer-level positions in corporate development and marketing. Prior to joining the company, Mr. Bradbury spent 10 years at SmithKline Beecham Pharmaceuticals, where he held a number of sales and marketing positions.

“I’ve had the pleasure of working with Dan for more than 11 years, first as a board member and then as a member of the management team. Dan has a deep appreciation for the two critical elements required to build a sustainable biopharmaceutical company: the value of scientific innovation and the importance of building capabilities to deliver those innovations to patients,” said Ms. Graham. “I look forward to Dan’s leadership and am excited to return to a role as a board member in support of Dan and the future success of Amylin.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters